文献速递神经肌肉病

验证MRC中心MRI小腿肌肉脂肪分数方案作为CMT1A转归指标

Validation of MRC Centre MRI calf muscle fat fraction protocol as an outcome measure in CMT1A.
PubMed 文献 · Neurology · 2018-08-17

本研究将MRC中心MRI定量方案转移至第二站点,在11例CMT1A患者(10例12个月后复扫)中验证小腿肌肉脂肪分数(FF)的反应性,并检验基线FF>10%分层能否提高反应性。结果显示FF重测信度良好,12个月显著增加,分层后反应性明显改善。

要点

  • 远程站点健康志愿者小腿肌肉FF重测信度优良:组内相关系数0.79,一致性界限-0.67至+0.85 %FF。
  • 患者平均小腿肌肉FF为21.0%,与疾病严重程度和年龄强相关。
  • 12个月内小腿肌肉FF显著增加+1.8±1.7 %FF(p=0.009);基线FF>10%者增加2.9%±1.3%(标准化反应均数=2.19)。

核心结论

  • 在独立CMT1A患者队列中验证小腿肌肉FF可作为转归指标,纳入基线小腿FF>10%的分层队列可显著提高反应性。

研究设计与样本

  • 3名健康志愿者用于站点间标准化;纵向患者研究招募11例CMT1A患者,其中10例在12个月间隔后复扫。
  • 对腿部肌肉行三点Dixon MRI生成脂肪分数(FF)图,传输至中心站点进行质控和分析;临床数据包括CMT神经病评分。

主要发现

  • 远程站点健康志愿者个体小腿肌肉FF重测信度优良:组内相关系数0.79,一致性界限-0.67至+0.85 %FF。
  • 患者平均小腿肌肉FF为21.0%,与疾病严重程度和年龄强相关。
  • 小腿肌肉FF在12个月内显著增加:+1.8±1.7 %FF(p=0.009)。
  • 基线FF>10%的患者12个月FF增加2.9%±1.3%(标准化反应均数=2.19)。

关键数值与推荐

  • 健康志愿者小腿肌肉FF重测信度:组内相关系数0.79,一致性界限-0.67至+0.85 %FF。
  • 患者平均小腿肌肉FF为21.0%。
  • 12个月小腿肌肉FF变化:+1.8±1.7 %FF(p=0.009)。
  • 基线FF>10%者12个月FF变化:2.9%±1.3%(标准化反应均数=2.19)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To translate the quantitative MRC Centre MRI protocol in Charcot-Marie-Tooth disease type 1A (CMT1A) to a second site; validate its responsiveness in an independent cohort; and test the benefit of participant stratification to increase outcome measure responsiveness. METHODS: Three healthy volunteers were scanned for intersite standardization. For the longitudinal patient study, 11 patients with CMT1A were recruited with 10 patients rescanned at a 12-month interval. Three-point Dixon MRI of leg muscles was performed to generate fat fraction (FF) maps, transferred to a central site for quality control and analysis. Clinical data collected included CMT Neuropathy Score. RESULTS: Test-retest reliability of FF within individual healthy calf muscles at the remote site was excellent: intraclass correlation coefficient 0.79, limits of agreement -0.67 to +0.85 %FF. In patients, mean calf muscle FF was 21.0% and correlated strongly with disease severity and age. Calf muscle FF significantly increased over 12 months (+1.8 ± 1.7 %FF, p = 0.009). Patients with baseline FF >10% showed a 12-month FF increase of 2.9% ± 1.3% (standardized response mean = 2.19). CONCLUSIONS: We have validated calf muscle FF as an outcome measure in an independent cohort of patients with CMT1A. Responsiveness is significantly improved by enrolling a stratified patient cohort with baseline calf FF >10%.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Morrow JM, Evans MRB, Grider T, et al. Validation of MRC Centre MRI calf muscle fat fraction protocol as an outcome measure in CMT1A. Neurology. 2018. PMID: 30120135. doi:10.1212/WNL.0000000000006214

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。